Aurora Recommended Hands Down over MedReleafSee excerpt from Small Cap Power article published yesterday on Aurora vs MedReleaf....Aurora wins handily.
https://smallcappower.com/analyst-articles/aurora-stock-price-medreleaf-tse-leaf/
Conclusion
Overall, both companies have the potential to generate above-average returns for investors heading into recreational legalization in Canada. While MedReleaf has an edge in its production-cost profile, adequate financing and high margins, positioning the company very well for sustainable growth, Aurora Cannabis has the clear upper hand with higher production capacity, double-digit growth rate, and more international opportunities in addition to synergies from the pending CanniMed acquisition. Thus, Aurora Cannabis looks much more attractive from an investment perspective and has the potential to provide much higher returns as compared with shares of MedReleaf.